Therefore, we speculated that FNDC4 might play an inhibitory role in hepatocellular carcinoma by affecting the expression activity of some inflammatory cytokines, such as CD40, TNFSF14 or CXCL2. Here, CXCL2 is linked to hepatocellular carcinoma.